POY_1170x120_8-12-19

Todd Zavodnick

Galderma debuts Excipial therapeutic skin care line

Galderma debuts Excipial therapeutic skin care line

FORT WORTH, Texas — This week, Galderma Laboratories expanded its therapeutic skin care roster with the launch of Excipial, a line of dermatologist-developed products formulated for “challenged skin.” Galderma said Thursday that Excipial includes five over-the-counter products: Excipial Daily Protection Hand Cream, Excipial Rapid Repair Hand Cream, Excipial 10% Urea Hydrating Healing Lotion, Excipial 20%

Galderma ships Epiduo Forte Gel

Galderma ships Epiduo Forte Gel

FORT WORTH, Texas — Galderma Laboratories has released Epiduo Forte Gel, a once-daily topical acne treatment, to retail pharmacies nationwide and in Puerto Rico. The medication, adapalene and benzoyl peroxide 0.3%/2.5%, received Food and Drug Administration approval last month. According to Galderma, Epiduo Forte Gel is the first combination of 0.3%/2.5% strengths of the retinoid

Galderma set to launch Epiduo Forte Gel

Galderma set to launch Epiduo Forte Gel

FORT WORTH, Texas — Galderma Laboratories has received Food and Drug Administration approval for antibiotic-free Epiduo Forte Gel (adapalene and benzoyl peroxide 0.3%/2.5%), a once-daily topical acne treatment. Galderma said Thursday Epiduo Forte Gel is the first combination of 0.3%/2.5% strengths of the retinoid adapalene and benzoyl peroxide developed for the moderate to severe acne

Galderma makes exec moves in business realignment

Galderma makes exec moves in business realignment

FORT WORTH, Texas — Galderma has made a series of executive appointments and announced a realignment of its North America business. The dermatology and skin care company said Thursday that Stuart Raetzman has been named as global chief executive officer of Galderma Pharma S.A. He reports to Humberto Antunes, chairman of Galderma Pharma S.A. and